Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: HEPATITIS B FOUNDATION
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-15 to 2022-09-16
Current total value of award: $63081
Description: EXECUTIVE ORDER 14042 --IMPROVING CLINICAL TRIAL DIVERSITY AND PARTICIPATION AMONG PEOPLE LIVING WITH CHRONIC HEPATITIS B  PERCEPTIONS AND CHALLENGES